|
LBPH | Longboard Pharmaceuticals, Inc. |
|
|
LBPH | Longboard Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.19 |
| Leverage | 7.35% |
| Market Cap | $ 1.4B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -75.9m |
| Margin | 0.00% |
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for neurological diseases. The company is headquartered in San Diego, California.